Coronavirus

Low-dose naltrexone use for the management of post-acute sequelae of COVID-19

Int Immunopharmacol
05 October 2023
https://pubmed.ncbi.nlm.nih.gov/37804660/

A key to a ‘faulty’ lock: Why Aussie researchers are excited about naltrexone for CFS

Ausdoc.com
31 July 2023
https://www.ausdoc.com.au/news/a-key-to-a-faulty-lock-why-aussie-researchers-are-excited-about-naltrexone-for-cfs/

 

Linda Elsegood: Today we're joined by pharmacist Dr Dawn Ipsen who's the owner of two pharmacies in Washington state. Kuslers Pharmacy and Clark Pharmacy. Could you tell us what it was that inspired you to become a pharmacist? 

Off-Label Meds: Promising Long COVID Treatments?

Medscape
28 July 2023
https://www.medscape.com/viewarticle/994728?form=fpf

With a lack of FDA-approved treatments, doctors who treat long COVID are turning to off-label use of drugs designed for addiction, diabetes, and other conditions.The FDA approves each drug to treat a specific condition. Off-label use, which is legal and common, allows doctors to prescribe drugs for another use.

D

Today we're joined by pharmacist Dr Dawn Ipsen who's the owner of two pharmacies in Washington State, Kuslers Pharmacy and Clark Pharmacy. Could you tell us what it was that inspired you to become a pharmacist?